Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    October 2018
  1. SUBRAMANIAN K, Dierckx T, Khouri R, Menezes SM, et al
    Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31922.
    PubMed     Text format     Abstract available


    September 2018
  2. DAVIS JM, Garb Y
    A strong spatial association between e-waste burn sites and childhood lymphoma in the West Bank, Palestine.
    Int J Cancer. 2018 Sep 27. doi: 10.1002/ijc.31902.
    PubMed     Text format     Abstract available


  3. CHATTOPADHYAY S, Sud A, Zheng G, Yu H, et al
    Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
    Int J Cancer. 2018 Sep 21. doi: 10.1002/ijc.31801.
    PubMed     Text format     Abstract available


  4. PURDUE MP, Lan Q, Hoffman-Bolton J, Hildesheim A, et al
    Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31879.
    PubMed     Text format     Abstract available


    May 2018
  5. CHIU YH, Bertrand KA, Zhang S, Laden F, et al
    A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31602.
    PubMed     Text format     Abstract available


  6. GAO R, Liang JH, Wang L, Zhu HY, et al
    Low Serum Cholesterol Levels Predict Inferior Prognosis and Improve NCCN-IPI Scoring in Diffuse Large B Cell Lymphoma.
    Int J Cancer. 2018 May 9. doi: 10.1002/ijc.31590.
    PubMed     Text format     Abstract available


    April 2018
  7. BANDAPALLI OR, Paramasivam N, Giangiobbe S, Kumar A, et al
    Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.
    Int J Cancer. 2018 Apr 30. doi: 10.1002/ijc.31576.
    PubMed     Text format    


  8. VERMEULEN R, Saberi Hosnijeh F, Bodinier B, Portengen L, et al
    Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma; univariate and functionally-informed multivariate analyses.
    Int J Cancer. 2018 Apr 18. doi: 10.1002/ijc.31536.
    PubMed     Text format     Abstract available


  9. RAASCHOU-NIELSEN O, Hvidtfeldt U, Roswall N, Hertel O, et al
    Ambient benzene at the residence and risk for subtypes of childhood leukaemia, lymphoma and CNS tumour.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31421.
    PubMed     Text format     Abstract available


    March 2018
  10. CALIP GS, Patel PR, Adimadhyam S, Xing S, et al
    Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions.
    Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31407.
    PubMed     Text format     Abstract available


  11. BASSIG BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, et al
    Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31385.
    PubMed     Text format     Abstract available


    November 2017
  12. COWELL JK, Qin H, Hu T, Wu Q, et al
    Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.
    Int J Cancer. 2017;141:1822-1829.
    PubMed     Text format     Abstract available


    October 2017
  13. JAYASEKARA H, Juneja S, Hodge AM, Room R, et al
    Lifetime alcohol intake and risk of non-Hodgkin lymphoma: Findings from the Melbourne Collaborative Cohort Study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31123.
    PubMed     Text format     Abstract available


  14. MAWSON AR, Majumdar S
    Malaria, Epstein-Barr virus, vitamin A, and Burkitt's lymphoma: Response to Joob and Wiwanitkit.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31122.
    PubMed     Text format    


  15. JOOB B, Wiwanitkit V
    Malaria, Epstein-Barr virus, vitamin A and Burkitt's lymphoma.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31118.
    PubMed     Text format    


  16. HOSRY J, Miranda RN, Samaniego F, Economides MP, et al
    Clinicopathologic Characteristics and Outcomes of Transformed Diffuse Large B-Cell Lymphoma in Hepatitis C Virus-Infected Patients.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31110.
    PubMed     Text format     Abstract available


  17. BIASOLI I, Castro N, Delamain M, Silveira T, et al
    Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients - an analysis from the Brazilian Hodgkin Lymphoma Registry.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31096.
    PubMed     Text format     Abstract available


    September 2017
  18. LI J, Wang X, Xie Y, Ying Z, et al
    The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31044.
    PubMed     Text format     Abstract available


    August 2017
  19. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    PubMed     Text format     Abstract available


  20. JOCHEMS C, Hodge JW, Fantini M, Tsang KY, et al
    ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.
    Int J Cancer. 2017;141:583-593.
    PubMed     Text format     Abstract available


    July 2017
  21. MAWSON AR, Majumdar S
    Malaria, Epstein-Barr virus infection, and the Pathogenesis of Burkitt's Lymphoma.
    Int J Cancer. 2017 Jul 13. doi: 10.1002/ijc.30885.
    PubMed     Text format     Abstract available


    June 2017
  22. ZENZ T, Kreuz M, Fuge M, Klapper W, et al
    TP53 mutation and survival in aggressive B cell lymphoma.
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30838.
    PubMed     Text format     Abstract available


    May 2017
  23. JANKET SJ, Ackerson LK, Meurman JH
    Potential reverse causation?
    Int J Cancer. 2017;140:2168.
    PubMed     Text format    


    April 2017
  24. HAVERKOS BM, Huang Y, Gru A, Pancholi P, et al
    Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
    Int J Cancer. 2017;140:1899-1906.
    PubMed     Text format     Abstract available


    March 2017
  25. SHETZER Y, Napchan Y, Kaufman T, Molchadsky A, et al
    Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
    Int J Cancer. 2017;140:1364-1369.
    PubMed     Text format     Abstract available


    November 2016
  26. ROTTENBERG Y, Levine H, Keinan-Boker L, Derazne E, et al
    Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30525.
    PubMed     Text format     Abstract available


    August 2016
  27. HALABI MA, Jaccard A, Moulinas R, Bahri R, et al
    Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
    Int J Cancer. 2016;139:793-802.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: